Formulate
Jobs
Companies
Products
Indications
Toggle theme
Toggle theme
Menu
Home
Products
TAZVERIK
TAZVERIK
Peak
tazemetostat hydrobromide
NDA
ORAL
TABLET
Priority Review
Approved
Jun 2020
Lifecycle
Peak
Competitive Pressure
30
/100
Overview
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers